CTx discovery was marked by a substantial rise of publications using this molecule for different applications, such as insecticide (DeBin et al., 1993), antiangiogenic (Jacoby et al., 2010), and tumor binding (Cohen-Inbar and Zaaroor, 2016). The gene discussed is CYP27A1; the disease is neoplasm.